Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Diseases”

15,064 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 15,064 results

Not applicableStudy completedNCT05792423
What this trial is testing

Conditionally Increased Output (CIO) Enhanced Ultrasound System

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisFatty Liver
Massachusetts General Hospital 24
Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Not applicableStudy completedNCT03245580
What this trial is testing

Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)

Who this might be right for
Liver Diseases
Parkview Health 153
Testing effectiveness (Phase 2)Looking for participantsNCT05844046
What this trial is testing

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Hepatocellular Carcinoma
Enrico De Toni 83
Post-approval studies (Phase 4)UnknownNCT03359746
What this trial is testing

Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant

Who this might be right for
Hepatitis C
King Faisal Specialist Hospital & Research Center 40
Not applicableNot Yet RecruitingNCT07618546
What this trial is testing

A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 208
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Not applicableNot Yet RecruitingNCT06872073
What this trial is testing

Assessment of Methotreaxate-induced Liver Fibrosis by Transient Elastography and Serological Markers

Who this might be right for
Liver Fibrosis
Assiut University 144
Testing effectiveness (Phase 2)Study completedNCT02745483
What this trial is testing

Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up Study

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 153
Testing effectiveness (Phase 2)WithdrawnNCT02420496
What this trial is testing

Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants

Who this might be right for
CholestasisLiver Disease
The University of Texas Health Science Center at San Antonio
Large-scale testing (Phase 3)Study completedNCT00039962
What this trial is testing

Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Who this might be right for
Hepatitis CHepatitis C, Chronic
SciClone Pharmaceuticals 500
Early research (Phase 1)Study completedNCT04812262
What this trial is testing

DD01 in Overweight/Obese Subjects With T2DM and NAFLD

Who this might be right for
Overweight and ObesityType2 DiabetesNAFLD
Neuraly, Inc. 255
Testing effectiveness (Phase 2)Study completedNCT02400788
What this trial is testing

Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Yakult Honsha Co., LTD 179
Testing effectiveness (Phase 2)UnknownNCT00294827
What this trial is testing

Liver Transplantation and Metastatic Colo-rectal Cancer.

Who this might be right for
Colo-rectal Cancer
Oslo University Hospital 25
Testing effectiveness (Phase 2)Ended earlyNCT01425970
What this trial is testing

Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 210
Not applicableStudy completedNCT06416683
What this trial is testing

Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen)

Who this might be right for
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
University Hospital, Caen 109
Not applicableStudy completedNCT01705041
What this trial is testing

Preliminary Evaluation of a Point-Of-Care Liver Function Test

Who this might be right for
HIVTuberculosisDrug-Induced Liver Injury
PATH 700
Not applicableLooking for participantsNCT07304466
What this trial is testing

Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation

Who this might be right for
Liver TransplantationPortal Hypertension
Istanbul Medipol University Hospital 50
Early research (Phase 1)Study completedNCT03418922
What this trial is testing

Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Eisai Co., Ltd. 30
Not applicableUnknownNCT06130202
What this trial is testing

Echocardiographic Findings as Markers of Subclinical Cardiac Dysfunction in Patients With Non-Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Assiut University 165
Next Page